Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07402226

Systemic Sclerosis DIet for GastrointESTinal Symptoms

This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of the diets will be available upon contact with the details listed below.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location status: Recruiting

Location contact

Dinesh Khanna, MD, MSc

PRINCIPAL_INVESTIGATOR

Rosemary Gedert

CONTACT

[email protected]

734-764-6466

About this study

The rationale for keeping the diets (arms/interventions names) vague is it prevents other researchers from using these diets in their studies, minimizes expectation bias of patients (who can have preference for one diet over other) and prevents participants from trying other diets before end of study period in case they don't respond.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of systemic sclerosis (SSc) as per ACR/EULAR classification criteria

.• Self-reported moderate to severe gastrointestinal bloating or distension, with a UCLA SCTC-GIT 2.0 bloating Scale score ≥2.00 on (0.00-3.00 scale) at screening.

  • Willingness and ability to comply with dietary intervention and study procedures.
  • Ability to provide informed consent.

Exclusion criteria

  • Diagnosis of inflammatory bowel disease (Crohn's disease or ulcerative colitis) or celiac disease.
  • Use of systemic antibiotics within 4 weeks prior to baseline.
  • History of gastrointestinal surgery (other than cholecystectomy or appendectomy unless in the last 3 months).
  • Severe cognitive impairment or psychiatric illness that would limit ability to follow dietary instructions.
  • Known allergy or intolerance to major components of any of the study diets (e.g., lactose, gluten) unless manageable within diet framework.
  • Current or recent (within 3 months) dietary intervention for managing GI symptoms (e.g. gluten-free diet, low FODMAP diet, etc.).
  • Clinically significant self-reported (≥10 percent weight loss) in the last 3 months
  • BMI less than 20
  • Ongoing tube feeds or TPN
  • Participating in another interventional trial
  • Pregnancy or lactation, or planning pregnancy in the next 6 months

Treatment and study plan

Diet 1: Restriction of fermentable carbohydrates

Behavioral

6 weeks guided diet under the supervision of a dietician restricting fermentable carbohydrates known to trigger GI symptoms.

Diet 2: Elimination of foods harmful to gut barrier and microbiome

Behavioral

6 weeks guided diet under the supervision of a dietician eliminating of foods harmful to gut barrier and microbiome

Diet 3: Regular meal patterns, soluble fiber, and portion control

Behavioral

6 weeks guided diet under the supervision of a dietician emphasizing regular meal patterns, soluble fiber, and portion control.

Primary outcomes

  1. Change in Bloating severity

    Time frame: Baseline to week 6

    As assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Scale v1.1 - Gastrointestinal Gas and Bloating 13a - 13 questions with raw summed scores ranging from 13-36.

Secondary outcomes

  1. Change in Bloating severity

    Time frame: Baseline to week 6

    As assessed by the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT 2.0). The bloating score is a subsection of 4 questions with 4 options each. The score ranges from .0-3 where higher numbers indicate more frequent bloating.

  2. Change in Abdominal pain severity

    Time frame: Baseline to week 6

    As assessed by the PROMIS Scale v1.0 - Gastrointestinal Belly Pain 5a - 5 questions with raw summed score range of 6-25.

  3. Change in Overall GI symptom

    Time frame: Baseline to week 6

    UCLA SCTC GIT 2.0 total score (all sections but constipation) with a range of (0-2.83). Higher scores indicate more severe symtoms.

Study contacts

Contact information is provided by the study sponsor or research team.

Rosemary Gedert

CONTACT

[email protected]

734-764-6466

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Registry information

Official study title

SSc-DIGEST Trial: Systemic Sclerosis DIet for GastrointESTinal Symptoms Randomized Controlled Trial of Low FODMAP, CDED, and NICE Diets for Gastrointestinal Symptoms in Systemic Sclerosis

Acronym: DIGEST

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 11, 2026
Registry last updated
Jul 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.